Francisco Silva, VP of Research and Development at BioRestorative Therapies, Inc. (BRTX), bought 4,000 shares at $6.66 ($27K) on 2021-11-19, disclosed to the SEC on 2021-11-22.
Open-market purchase of $27k BRTX by VP of Research and Development. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |
| BRTX | BUY | 2023-04-04 | $3K | — | Filing → |
| BRTX | BUY | 2022-11-21 | $2K | — | Filing → |
| BRTX | BUY | 2022-10-12 | $3K | — | Filing → |